JG
SLS icon

Jefferies Group’s SELLAS Life Sciences SLS Stock Holding History

Jefferies Group’s Portfolio SLS Stock Details SLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-11,800
Closed -$131K – 1991
2021
Q2 		$131K Hold
11,800
– – ﹤0.01% 1461
2021
Q1 		$101K Buy
+11,800
New +$96.5K ﹤0.01% 1442

Other funds holding SLS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
EH
Equitable Holdings New York $15.5B AUM 19.09% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Jefferies Group's SLS Position: Q3 2021 in Review

Jefferies Group sold out of SELLAS Life Sciences (SLS) in Q3 2021, closing a stake of 150,000 shares — an estimated $1.67M sold.

Jefferies Group first reported a position in SLS in Q1 2021 and held it in 2 quarters. The position peaked at $1.67M in Q2 2021. 30 funds tracked by Wall St. Rank hold SLS as of Q3 2021.

  • Jefferies Group reported no remaining SELLAS Life Sciences position as of Q3 2021 after selling out during the quarter.
  • Jefferies Group sold 150,000 SELLAS Life Sciences shares in Q3 2021, an estimated $1.67M.
  • Jefferies Group first reported a position in SELLAS Life Sciences in Q1 2021 and held it in 2 quarters.
  • Jefferies Group's SELLAS Life Sciences position peaked at $1.67M in Q2 2021.
  • 30 funds tracked by Wall St. Rank held SELLAS Life Sciences as of Q3 2021.

Based on Jefferies Group's 13F filing for Q3 2021, filed 15 Nov 2021.